Loading
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
Latest quote
$0.37
+$0.0007 · +0.19%
After-hours
$0.37
$0.00 · 0.00%
Oct 9, 7:57 PM ET
Regular session · ET · Market data may be delayed.
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
Day range
Current $0.37
52-week range
Current $0.37
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
44
Fair Value
Sentiment
50
Mixed
Risk
67
High Risk
Momentum
20
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
Day range
Current $0.37
52-week range
Current $0.37
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 4.86M USD | 3.37M USD | 2.4M USD | 3.59M USD | — |
| Cost of goods sold | 3.3M USD | 2.07M USD | 1.8M USD | 1.62M USD | — |
| Gross profit | 1.56M USD | 1.3M USD | 598.93K USD | 1.98M USD | — |
| Selling, general, and administrative | 3.7M USD | 2.67M USD | 2.09M USD | 26.09M USD | 135.65K USD |
| Operating expenses | 4.94M USD | 3.8M USD | 3.01M USD | 2.51M USD | 135.65K USD |
| Interest income | 3.86K USD | 123 USD | — | — | 99 USD |
| Interest expense | 50.46K USD | 48.28K USD | 42.84K USD | 46.61K USD | — |
| Depreciation and amortization | 1.13M USD | 1.13M USD | 903.44K USD | 898.63K USD | — |
| Operating income | −3.38M USD | −2.5M USD | −2.41M USD | −535.45K USD | −135.65K USD |
| Net income | −2.01M USD | −2.51M USD | −2.3M USD | −729.16K USD | −119.63K USD |
Company facts updated Oct 10, 2026.
Recent quarterly results
Recent quarterly results
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
